Is Hormel’s Lowered 2026 EPS Outlook Reshaping the Investment Case for Hormel Foods (HRL)?

Hormel Foods Corporation

Hormel Foods Corporation

HRL

0.00

  • Hormel Foods recently reported second-quarter 2026 results showing sales of about US$2,972.6 million and a year-on-year drop in net income and earnings per share from continuing operations, while also lowering full-year diluted EPS guidance to US$1.28–US$1.37 and trimming operating income expectations due to the sale of its whole-bird turkey business.
  • These updates suggest Hormel is absorbing a near-term earnings hit as it reshapes its portfolio, raising questions about how quickly its modernization and margin initiatives can offset the impact of divestitures and cost pressures.
  • Next, we’ll examine how the reduced full-year earnings guidance reshapes Hormel Foods’ existing investment narrative around margins and modernization.

AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Hormel Foods Investment Narrative Recap

To own Hormel Foods, you generally have to believe in its ability to gradually rebuild margins while modernizing a mature branded food portfolio. The latest quarter’s softer earnings and lower full year EPS guidance reinforce that the key short term catalyst is margin stabilization, while the biggest risk remains ongoing cost pressure and slower pass through of price increases; the turkey divestiture related hit looks material enough to keep that risk front of mind.

The most relevant update here is Hormel’s cut to full year operating income and diluted EPS guidance to US$0.96–US$1.02 billion and US$1.28–US$1.37 per share, respectively, reflecting the loss on the whole bird turkey sale. That guidance move sits directly against investors’ focus on margin recovery and modernization, because it shows how portfolio reshaping and one off items are still weighing on near term profitability even as revenue guidance is held steady.

Yet while guidance has only been trimmed, the ongoing risk that higher input costs and slow pricing pass through keep margins under pressure is something investors need to be aware of...

Hormel Foods' narrative projects $12.9 billion revenue and $872.4 million earnings by 2029.

Uncover how Hormel Foods' forecasts yield a $26.50 fair value, a 11% upside to its current price.

Exploring Other Perspectives

HRL 1-Year Stock Price Chart
HRL 1-Year Stock Price Chart

Three members of the Simply Wall St Community currently estimate Hormel’s fair value between US$26.50 and about US$39.21, showing a wide spread of views. You can set those against the recent guidance cut, which keeps the focus firmly on how input cost volatility and pricing lags might continue to shape Hormel’s earnings profile.

Explore 3 other fair value estimates on Hormel Foods - why the stock might be worth as much as 64% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Hormel Foods research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
  • Our free Hormel Foods research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Hormel Foods' overall financial health at a glance.

Contemplating Other Strategies?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

  • Invest in the nuclear renaissance through our list of 88 elite nuclear energy infrastructure plays powering the global AI revolution.
  • Find 46 companies with promising cash flow potential yet trading below their fair value.
  • Uncover the next big thing with 24 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.